Summit Securities Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$33.1K 1132
2025
Q1
$33.1K Buy
+100
New +$33.1K 0.01% 273
2024
Q2
Hold
0
562
2024
Q1
Hold
0
568
2013
Q4
Sell
-94
Closed -$21K 459
2013
Q3
$21K Buy
94
+62
+194% +$13.9K 0.01% 215
2013
Q2
$6K Buy
+32
New +$6K ﹤0.01% 289